Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Abnormal accumulation of β-amyloid (Aβ) in Alzheimer's disease (AD) is associated with prominent brain inflammation. Whereas earlier studies concluded that this inflammation is detrimental, more recent animal data suggest that at least some inflammatory processes may be beneficial and promote Aβ clearance. Consistent with these observations, overproduction of transforming growth factor (TGF)-β1 resulted in a vigorous microglial activation that was accompanied by at least a 50% reduction in Aβ accumulation in human amyloid precursor protein (hAPP) transgenic mice. In a search for inflammatory mediators associated with this reduced pathology, we found that brain levels of C3, the central component of complement and a key inflammatory protein activated in AD, were markedly higher in hAPP/TGF-β1 mice than in hAPP mice. To assess the importance of complement in the pathogenesis of AD-like disease in mice, we inhibited C3 activation by expressing soluble complement receptor-related protein y (sCrry), a complement inhibitor, in the brains of hAPP mice. Aβ deposition was 2- to 3-fold higher in 1-year-old hAPP/sCrry mice than in age-matched hAPP mice and was accompanied by a prominent accumulation of degenerating neurons. These results indicate that complement activation products can protect against Aβ-induced neurotoxicity and may reduce the accumulation or promote the clearance of amyloid and degenerating neurons. These findings provide evidence for a role of complement and innate immune responses in AD-like disease in mice and support the concept that certain inflammatory defense mechanisms in the brain may be beneficial in neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“other studies have reported that inhibition of different components of complement impaired Aβ phagocytosis, resulting in elevated synapse loss.”
From Microglia in Alzheimer's disease (2017) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The deficiency of complement factors such as C1q, C3, C3ar1, C5aR, and Cd59, has exacerbated neuropathology in some studies [84–86] and reduced neuropathology in others [87–89].”
From Age, sex and Alzheimer’s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer’s patients (2024) · cites this paper as [85]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the same studies, complement blockade was associated with increased neurodegeneration.”
From Microglia in Alzheimer's disease (2017) · cites this paper as [122]
The cited source says what the claim attributes to it.
In the citing paper
“C3 inhibition enhanced plaque deposition and promoted neurodegeneration in J20 hAPP mice either by over-expression of sCrry (22) or genetic deletion of C3 (21).”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Further, studies manipulating the complement system have yielded mixed results.”
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Self-citationImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cellular Scaling Rules for the Brains of Marsupials: Not as “Primitive” as Expected
Dos Santos, S. E., Porfirio, J., da Cunha, F. B., Manger, P. R., Tavares, W., Pessoa, L., Raghanti, M. A., Sherwood, C. C., & Herculano-Houzel, S. (2017) · Brain, Behavior and Evolution · doi:10.1159/000452856 · Cited by 2,642
NeuN, a neuronal specific nuclear protein in vertebratesxs
Mullen, R. J., Buck, C. R., & Smith, A. M. (1992) · Development · doi:10.1242/dev.116.1.201 · Cited by 2,351
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Self-citationAβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
Self-citation
Research works printed but not linked: 4
- Wyss-Coray, T. & Mucke, L. (2002) Neuron, in press. [DOI] [PubMed]
- Terry R. D., Masliah, E. & Hansen, L. A. (1994) in Alzheimer Disease, eds. Terry, R. D., Katzman, R. & Bick, K. L. (Raven, New York), pp. 179–196.
- Frautschy S. A., Cole, G. M. & Baird, A. (1992) Am. J. Pathol. 140, 1389-1399. [PMC free article] [PubMed] [Google Scholar]
- Holers V. M. (1996) in Clinical Immunology: Principles and Practice, ed. Rich, R. R. (Mosby, St. Louis), pp. 363–391.
Cited by
Items 401–466 of 466
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 2
Brain Inflammation and the Neuronal Fate: from Neurogenesis to Neurodegeneration
Ajmone‐Cat, M. A., Cacci, E., & Minghetti, L. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195326697.003.0013 · Cited by 1
Carbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Hodgkinson, A., Dobson, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452732 · Cited by 2
“Others show loss of complement function leads to poorer outcomes in AD (Wyss-Coray et al., 2002; Maier et al., 2008) and mutations (particularly in C1QA) linked to SLE result in greater autoantibody production and loss of immunotolerance (Sontheimer et al., 2005).”
BackgroundLoeffler, D. A. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0290-z · Cited by 1
Immune regulations in a Drosophila model of Alzheimer's disease
Maksoud, É. (2012) · theses.fr (ABES) · doi:10.70675/1c0d2d8cz36d8z4785zbf04z131c36133de9 · Cited by 2
Herber, D. L. (2004) · Digital Commons - University of South Florida (University of South Florida)
Simmons, C. R. (2011) · UKnowledge (University of Kentucky)
Augé, C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003617456 · Cited by 1
Neural networks in a mouse model of amyloid pathology
Palmer, A. M. (2012) · ORCA Online Research @Cardiff (Cardiff University)
The role of complement anaphylatoxins in CNS pathology and glial cell function
Ingersoll, S. A. (2010) · doi:10.17077/etd.k0bgyd8z
“Interestingly, another study found that when a soluble form of Crry (sCrry) was expressed, plaque formation was increased and neurodegeneration was worsened (73), suggesting that some complement activation is beneficial to AD”
BackgroundSarlus, H. (2015) · Figshare
Further insights into Alzheimer's disease
Sims, R., Gerrish, A., & Williams, J. H. (2012) · Quality in Ageing and Older Adults · doi:10.1108/14717791211264043
“This theory is supported by AD mouse models where inhibition of complement activation has been shown to correlate with enhanced Ab plaque deposition and loss of neuronal integrity (Wyss-Coray et al., 2002; Maier et al., 2008).”
BackgroundP2‐030: INVESTIGATING THE ROLE OF CLU, PICALM, AND CR1 IN ALZHEIMER'S DISEASE
Lord, J., Turton, J. C., Braae, A., Barber, I., Medway, C., Brown, K. S., & Morgan, K. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.703
Genetic dissection of models for neuroinflammation and neurodegeneration
Harnesk, K. (2009) · Figshare
The older brain, inflammation, vaccination and the prevention of dementia
Neal, J. (2010) · Reviews in Clinical Gerontology · doi:10.1017/s0959259810000183
Genetic regulation of nerve injury-induced neurodegeneration and inflammation
Swanberg, M. (2007) · Figshare
The role of Kat2a during memory formation and chromatin plasticity in the aging murine hippocampus
Stilling, R. M. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3945
Sorting Nexin 27 Regulates Ab Production through Modulating g-Secretase Activity
Wang, X., Huang, T. Y., Hong, W., & Xu, H. (2014)
Antibody Therapy Against β-Amyloid to Treat Alzheimer’s Disease
Bard, F., Seubert, P. A., Schenk, D., & Yednock, T. A. (2003) · Springer eBooks · doi:10.1007/978-3-642-59332-1_7
HIV Dementia: A Neurodegenerative Disorder with Viral Etiology
Koutsilieri, E., Arendt, G., Neuen-Jacob, E., Scheller, C., Grünblatt, E., & Riederer, P. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_17
Neuroinflammation in Huntington’s & Related Neurodegenerative Disorders
Tripathi, V. K., & Jana, N. R. (2016) · Springer eBooks · doi:10.1007/978-981-10-1711-7_6
Microglia and Complement in Alzheimer's Disease with Cerebral Amyloid Angiopathy
Zabel, M. K. (2013) · The Scholars Repository - LLU (Loma Linda University)
The Search for Biomarkers in Alzheimer's Disease
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.107 · Cited by 3
Inflammatory pathology in neurodegenerative dementias
Niedermayer, G. (2014)
Proteolysis of CX3CL1 Impacts CX3CR1 Signaling and Therapeutic Benefits in a Tauopathy Model
Finneran, D. J. (2018) · Digital Commons - University of South Florida (University of South Florida)
Study of the importance of the choroid plexus in peripheral and brain inflammation
Gorlé, N. (2020) · Ghent University Academic Bibliography (Ghent University)
Doroshenko, E. R. (2019) · TSpace (University of Toronto)
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
“Blocking C3, which is predominantly secreted from Introduction 20| P a g e reactive astrocytes, resulted in increased Aβ-burden with no impact on neuronal loss (Maier et al., 2008; Shi et al., 2017; Wyss-Coray et al., 2002).”
BackgroundImplicación de la disfunción glial en la evolución de la patología en pacientes de Alzheimer
Castro, M., & Clara (2021) · Deposito de Investigacion Universidad de Sevilla (University of Seville) · Cited by 1
Vincent, A. C. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1108980.566140
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7
Pathogenesis of Alzheimer Disease: Metabolic Factors
(2004) · Springer eBooks · doi:10.1007/0-306-48529-x_15
Ghebrehiwet, B. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726556801.793570695
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Zhang, Y., Hamamy, A. E., Iqbal, Z., Ranjan, A., Sumani, D., Lin, H. W., McCullough, L. D., & Li, J. (2025) · Aging and Disease · doi:10.14336/ad.2025.0474 · Cited by 1
“Elevated TGF-β levels correlate with increased C3 expression in dementia patients [55], suggesting a TGF-β may be a contributor to A1 activation.”
Carotenoids and Memory Enhancement: A Therapeutic Link to Alzheimer’s Disease
Choudhary, S., Aggarwal, N., & Bansal, S. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_12
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26085212
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737959
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737980
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737965
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737977
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737971
Central mechanisms of pain transmission
Keyes, A. L. (2023) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.006931
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737962
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26085125
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737974
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737983
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737956
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737968
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737986
Mecanismos Bioquímicos y Moleculares de la Neurodegeneración en la Enfermedad de Alzheimer
Campo-Palacio, I. (2023) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Neuroinflammation in Alzheimer's Disease: a therapeutic target
Zhu, S. (2020) · Mspace (University of Manitoba)
Acetylcholine and Cholinergic Modulation of Immune Responses
Nizri, E., & Brenner, T. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0888-8_3
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c · Cited by 1
Le polymorphisme du promoteur de l'interleukine-10 et son rôle éventuel dans la maladie d'Alzheimer
Asselineau, D. (2014) · theses.fr (ABES) · doi:10.70675/005990fbzcafez46ecz96abzefcc314e15aa
Mahmoudi, A.-E.-R. (2015) · theses.fr (ABES) · doi:10.70675/5f05520ez1713z4991za6c8z055ab117e2bb
Étude de la composante neuroinflammatoire dans les DFT/SLA
Smeyers, J. (2020) · theses.fr (ABES) · doi:10.70675/219cfa6fz5b3az4198z9deczdfaad3cd784c
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Nadarajah, C. J., Li, M. Y., Park, S., Lawrence, J. H., Sharma, A., Danhash, E., Karch, C. M. M., & Musiek, E. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.09.750237
“…complement is thought to modulate AD-related neuroinflammation and thereby regulate pathology. β Genetic deletion of C3 or inhibiting C3 activation worsened A plaque accumulation in aged AD-mouse models 17,18 ; presumably by limiting C3-mediated opsonization and glial clearance of amyloid.”
Gupta, S., Shenoy, A., Chaudhari, V., Buttar, H. S. ;. D. O. P. A. L. M., Chintamaneni, M., & Kaur, G. (2021) · Biomedical Reviews · doi:10.14748/bmr.v32.8496
Gupta, A. (2022) · Journal of Positive School Psychology
Jennette, K. J. (2015) · Digital Commons - University of South Florida (University of South Florida)
Metadata
- Authors
- Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E.
- Affiliations
- Gladstone Institute of Neurological Disease and Department of Neurology, University of California, San Francisco, CA 94141; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; Department of Medicine, Section of Nephrology, University of Chicago, Chicago, IL 60637; and Departments of Neurosciences and Pathology, University of California at San Diego, La Jolla, CA 92093
- University of California, San Francisco (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-07-15
- Volume
- 99
- Issue
- 16
- Pages
- 10837-10842
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC125059
- OpenAlex
- W2047658053
- Cited by
- 446
- References
- 47
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 18 · 2023: 10 · 2022: 13 · 2021: 19 · 2020: 24 · 2019: 21 · 2018: 16 · 2017: 11 · 2016: 13 · 2015: 18 · 2014: 20 · 2013: 17 · 2012: 28
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01ag015871-01a1, AG5131, n01ai30040-13-0-5, 5r29ag010869-05, AI-30040, AG10869, AG15871)
- National Institute on Aging (P50AG005131, AG-5131, AG10869, AG15871)
- National Institute of Allergy and Infectious Diseases (AI30040, N01 AI030040)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK41873, DK58820, R56DK041873, R01DK041873, U24DK058820)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- Alzheimer's disease, complement activation, complement C3, amyloid-beta deposition, amyloid plaques, neurodegeneration, TGF-β1, microglial activation, innate immunity, amyloid precursor protein transgenic mice, neuroinflammation, amyloid clearance
- MeSH terms
- Alzheimer Disease, Animals, Brain, Complement Activation, Complement C3, Disease Models, Animal, Humans, Mice, Inbred C57BL, Mice, Transgenic, Nerve Degeneration, Neurons, Receptors, Complement, Gene Expression, Amyloid beta-Protein Precursor, Receptors, Complement 3b, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.